aluates Reports

$ 0.0

Automative

Global Polio Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-18B4237

Global Polio Vaccine Market Research Report 2021

BUY CHAPTERS

Global Polio Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-18B4237

Report

June 2025

Pages:140

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Polio Vaccine Market Size

In 2024, the global market size of Polio Vaccine was estimated to be worth US$ 770 million and is forecast to reach approximately US$ 1023 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

Polio Vaccine Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.

The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Polio Vaccine Market Report

Report Metric	Details
Report Name	Polio Vaccine Market
CAGR	4.2%
Segment by Type	Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV)
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Polio Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Polio Vaccine Market?

Ans: Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Who are the main players in the Polio Vaccine Market report?

Ans: The main players in the Polio Vaccine Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Polio Vaccine Market report?

Ans: The Applications covered in the Polio Vaccine Market report are Public, Private

What are the Type segmentation covered in the Polio Vaccine Market report?

Ans: The Types covered in the Polio Vaccine Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

1 Study Coverage

1.1 Polio Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Polio Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Inactivated Polio Vaccine (IPV)

1.2.3 Oral Polio Vaccine (OPV)

1.3 Market by Application

1.3.1 Global Polio Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Public

1.3.3 Private

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Polio Vaccine Market Size Estimates and Forecasts

2.1.1 Global Polio Vaccine Revenue 2020-2031

2.1.2 Global Polio Vaccine Sales 2020-2031

2.2 Polio Vaccine Market Size by Region: 2024 Versus 2031

2.3 Polio Vaccine Sales by Region (2020-2031)

2.3.1 Global Polio Vaccine Sales by Region: 2020-2025

2.3.2 Global Polio Vaccine Sales Forecast by Region (2026-2031)

2.3.3 Global Polio Vaccine Sales Market Share by Region (2020-2031)

2.4 Polio Vaccine Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Polio Vaccine Revenue by Region: 2020-2025

2.4.2 Global Polio Vaccine Revenue Forecast by Region (2026-2031)

2.4.3 Global Polio Vaccine Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Polio Vaccine Sales by Type (2020-2031)

3.1.1.1 Global Polio Vaccine Sales Volume by Type (2020-2031)

3.1.1.2 Global Polio Vaccine Sales Market Share by Type (2020-2031)

3.1.2 Global Polio Vaccine Revenue by Type (2020-2031)

3.1.2.1 Global Polio Vaccine Revenue by Type (2020-2031)

3.1.2.2 Global Polio Vaccine Revenue Market Share by Type (2020-2031)

3.1.3 Polio Vaccine Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Polio Vaccine Sales by Application (2020-2031)

3.2.1.1 Global Polio Vaccine Sales Volume by Application (2020-2031)

3.2.1.2 Global Polio Vaccine Sales Market Share by Application (2020-2031)

3.2.2 Global Polio Vaccine Revenue by Application (2020-2031)

3.2.2.1 Global Polio Vaccine Revenue by Application (2020-2031)

3.2.2.2 Global Polio Vaccine Revenue Market Share by Application (2020-2031)

3.2.3 Polio Vaccine Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Inactivated Polio Vaccine (IPV) of Polio Vaccine Revenue Market Share by Application

3.3.2 Oral Polio Vaccine (OPV) of Polio Vaccine Revenue Market Share by Application

4 Global Polio Vaccine by Manufacturers

4.1 Global Top Polio Vaccine Manufacturers by Sales (2020-2025)

4.1.1 Global Polio Vaccine Sales by Manufacturer (2020-2025)

4.1.2 Global Polio Vaccine Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Polio Vaccine Manufacturers by Revenue (2020-2025)

4.2.1 Global Polio Vaccine Revenue by Manufacturer (2020-2025)

4.2.2 Global Polio Vaccine Revenue Share by Manufacturer (2020-2025)

4.3 Global Polio Vaccine Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Polio Vaccine Manufacturers Covered: Ranking by Revenue

4.4.2 Global Polio Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Polio Vaccine Manufacturing Base Distribution, Product Type

4.5.1 Polio Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Polio Vaccine Market

4.5.3 Manufacturers Polio Vaccine Product Type and Application

4.5.4 Inactivated Polio Vaccine (IPV) Market Sales of Polio Vaccine by Manufacturer

4.5.5 Oral Polio Vaccine (OPV) Market Sales of Polio Vaccine by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Sanofi

5.1.1 Sanofi Company Information

5.1.2 Sanofi Description, Business Overview

5.1.3 Sanofi Polio Vaccine Products Offered

5.1.4 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Sanofi Polio Vaccine Sales by Product in 2024

5.1.6 Sanofi Polio Vaccine Sales by Application in 2024

5.1.7 Sanofi Polio Vaccine Sales by Geographic Area in 2024

5.1.8 Sanofi Recent Developments

5.2 GSK

5.2.1 GSK Company Information

5.2.2 GSK Description, Business Overview

5.2.3 GSK Polio Vaccine Products Offered

5.2.4 GSK Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.2.5 GSK Polio Vaccine Sales by Product in 2024

5.2.6 GSK Polio Vaccine Sales by Application in 2024

5.2.7 GSK Polio Vaccine Sales by Geographic Area in 2024

5.2.8 GSK Recent Developments

5.3 Bibcol

5.3.1 Bibcol Company Information

5.3.2 Bibcol Description, Business Overview

5.3.3 Bibcol Polio Vaccine Products Offered

5.3.4 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Bibcol Polio Vaccine Sales by Product in 2024

5.3.6 Bibcol Polio Vaccine Sales by Application in 2024

5.3.7 Bibcol Polio Vaccine Sales by Geographic Area in 2024

5.3.8 Bibcol Recent Developments

5.4 Serum Institute

5.4.1 Serum Institute Company Information

5.4.2 Serum Institute Description, Business Overview

5.4.3 Serum Institute Polio Vaccine Products Offered

5.4.4 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Serum Institute Polio Vaccine Sales by Product in 2024

5.4.6 Serum Institute Polio Vaccine Sales by Application in 2024

5.4.7 Serum Institute Polio Vaccine Sales by Geographic Area in 2024

5.4.8 Serum Institute Recent Developments

5.5 Tiantan Biological

5.5.1 Tiantan Biological Company Information

5.5.2 Tiantan Biological Description, Business Overview

5.5.3 Tiantan Biological Polio Vaccine Products Offered

5.5.4 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Tiantan Biological Polio Vaccine Sales by Product in 2024

5.5.6 Tiantan Biological Polio Vaccine Sales by Application in 2024

5.5.7 Tiantan Biological Polio Vaccine Sales by Geographic Area in 2024

5.5.8 Tiantan Biological Recent Developments

5.6 IMBCA

5.6.1 IMBCA Company Information

5.6.2 IMBCA Description, Business Overview

5.6.3 IMBCA Polio Vaccine Products Offered

5.6.4 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.6.5 IMBCA Polio Vaccine Sales by Product in 2024

5.6.6 IMBCA Polio Vaccine Sales by Application in 2024

5.6.7 IMBCA Polio Vaccine Sales by Geographic Area in 2024

5.6.8 IMBCA Recent Developments

5.7 Panacea Biotec Ltd

5.7.1 Panacea Biotec Ltd Company Information

5.7.2 Panacea Biotec Ltd Description, Business Overview

5.7.3 Panacea Biotec Ltd Polio Vaccine Products Offered

5.7.4 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Panacea Biotec Ltd Polio Vaccine Sales by Product in 2024

5.7.6 Panacea Biotec Ltd Polio Vaccine Sales by Application in 2024

5.7.7 Panacea Biotec Ltd Polio Vaccine Sales by Geographic Area in 2024

5.7.8 Panacea Biotec Ltd Recent Developments

5.8 Bio-Med

5.8.1 Bio-Med Company Information

5.8.2 Bio-Med Description, Business Overview

5.8.3 Bio-Med Polio Vaccine Products Offered

5.8.4 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Bio-Med Polio Vaccine Sales by Product in 2024

5.8.6 Bio-Med Polio Vaccine Sales by Application in 2024

5.8.7 Bio-Med Polio Vaccine Sales by Geographic Area in 2024

5.8.8 Bio-Med Recent Developments

5.9 Halfkin Bio-Pharmaceuticals

5.9.1 Halfkin Bio-Pharmaceuticals Company Information

5.9.2 Halfkin Bio-Pharmaceuticals Description, Business Overview

5.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Products Offered

5.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales by Product in 2024

5.9.6 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales by Application in 2024

5.9.7 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales by Geographic Area in 2024

5.9.8 Halfkin Bio-Pharmaceuticals Recent Developments

6 North America

6.1 North America Polio Vaccine Market Size YoY Growth 2020-2031

6.2 North America Polio Vaccine Market Facts & Figures by Country

6.2.1 North America Polio Vaccine Sales by Country (2020-2031)

6.2.2 North America Polio Vaccine Revenue by Country (2020-2031)

6.3 North America Polio Vaccine Sales by Type (2020-2025)

6.4 North America Polio Vaccine Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Polio Vaccine Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Polio Vaccine Market Facts & Figures by Region

7.2.1 Asia-Pacific Polio Vaccine Sales by Region (2020-2031)

7.2.2 Asia-Pacific Polio Vaccine Revenue by Region (2020-2031)

7.3 Asia-Pacific Polio Vaccine Sales by Type (2020-2025)

7.4 Asia-Pacific Polio Vaccine Sales by Application (2020-2025)

8 Europe

8.1 Europe Polio Vaccine Market Size YoY Growth 2020-2031

8.2 Europe Polio Vaccine Market Facts & Figures by Country

8.2.1 Europe Polio Vaccine Sales by Country (2020-2031)

8.2.2 Europe Polio Vaccine Revenue by Country (2020-2031)

8.3 Europe Polio Vaccine Sales by Type (2020-2025)

8.4 Europe Polio Vaccine Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Polio Vaccine Market Size YoY Growth 2020-2031

9.2 Latin America Polio Vaccine Market Facts & Figures by Country

9.2.1 Latin America Polio Vaccine Sales by Country (2020-2031)

9.2.2 Latin America Polio Vaccine Revenue by Country (2020-2031)

9.3 Latin America Polio Vaccine Sales by Type (2020-2025)

9.4 Latin America Polio Vaccine Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Polio Vaccine Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Polio Vaccine Market Facts & Figures by Country

10.2.1 Middle East and Africa Polio Vaccine Sales by Country (2020-2031)

10.2.2 Middle East and Africa Polio Vaccine Revenue by Country (2020-2031)

10.3 Middle East and Africa Polio Vaccine Sales by Type (2020-2025)

10.4 Middle East and Africa Polio Vaccine Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Polio Vaccine Supply Chain Analysis

11.2 Polio Vaccine Key Raw Materials and Upstream Suppliers

11.3 Polio Vaccine Clients Analysis

11.4 Polio Vaccine Sales Channel and Sales Model Analysis

11.4.1 Polio Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Polio Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Polio Vaccine Distributors

12 Polio Vaccine Market Dynamics

12.1 Polio Vaccine Industry Trends

12.2 Polio Vaccine Market Drivers

12.3 Polio Vaccine Market Challenges

12.4 Polio Vaccine Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

List of Tables

Table 1. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Polio Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Polio Vaccine Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Polio Vaccine Sales by Region (2020-2025) & (K Units)

Table 5. Global Polio Vaccine Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Polio Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Polio Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Polio Vaccine Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Polio Vaccine Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Polio Vaccine Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Polio Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Polio Vaccine Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Polio Vaccine Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Polio Vaccine Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Polio Vaccine Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Polio Vaccine Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Polio Vaccine Sales Share by Manufacturer (2020-2025)

Table 18. Polio Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Polio Vaccine Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Polio Vaccine Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Polio Vaccine Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccine as of 2024)

Table 24. Polio Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Polio Vaccine Market

Table 26. Manufacturers Polio Vaccine Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Sanofi Company Information

Table 29. Sanofi Description and Business Overview

Table 30. Sanofi Polio Vaccine Product

Table 31. Sanofi Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Sanofi Sales Proportion of Polio Vaccine by Product in 2024

Table 33. Sanofi Sales Proportion of Polio Vaccine by Application in 2024

Table 34. Sanofi Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 35. Sanofi Recent Developments

Table 36. GSK Company Information

Table 37. GSK Description and Business Overview

Table 38. GSK Polio Vaccine Product

Table 39. GSK Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. GSK Sales Proportion of Polio Vaccine by Product in 2024

Table 41. GSK Sales Proportion of Polio Vaccine by Application in 2024

Table 42. GSK Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 43. GSK Recent Developments

Table 44. Bibcol Company Information

Table 45. Bibcol Description and Business Overview

Table 46. Bibcol Polio Vaccine Product

Table 47. Bibcol Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Bibcol Sales Proportion of Polio Vaccine by Product in 2024

Table 49. Bibcol Sales Proportion of Polio Vaccine by Application in 2024

Table 50. Bibcol Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 51. Bibcol Recent Developments

Table 52. Serum Institute Company Information

Table 53. Serum Institute Description and Business Overview

Table 54. Serum Institute Polio Vaccine Product

Table 55. Serum Institute Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Serum Institute Sales Proportion of Polio Vaccine by Product in 2024

Table 57. Serum Institute Sales Proportion of Polio Vaccine by Application in 2024

Table 58. Serum Institute Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 59. Serum Institute Recent Developments

Table 60. Tiantan Biological Company Information

Table 61. Tiantan Biological Description and Business Overview

Table 62. Tiantan Biological Polio Vaccine Product

Table 63. Tiantan Biological Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Tiantan Biological Sales Proportion of Polio Vaccine by Product in 2024

Table 65. Tiantan Biological Sales Proportion of Polio Vaccine by Application in 2024

Table 66. Tiantan Biological Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 67. Tiantan Biological Recent Developments

Table 68. IMBCA Company Information

Table 69. IMBCA Description and Business Overview

Table 70. IMBCA Polio Vaccine Product

Table 71. IMBCA Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. IMBCA Sales Proportion of Polio Vaccine by Product in 2024

Table 73. IMBCA Sales Proportion of Polio Vaccine by Application in 2024

Table 74. IMBCA Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 75. IMBCA Recent Developments

Table 76. Panacea Biotec Ltd Company Information

Table 77. Panacea Biotec Ltd Description and Business Overview

Table 78. Panacea Biotec Ltd Polio Vaccine Product

Table 79. Panacea Biotec Ltd Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Panacea Biotec Ltd Sales Proportion of Polio Vaccine by Product in 2024

Table 81. Panacea Biotec Ltd Sales Proportion of Polio Vaccine by Application in 2024

Table 82. Panacea Biotec Ltd Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 83. Panacea Biotec Ltd Recent Developments

Table 84. Bio-Med Company Information

Table 85. Bio-Med Description and Business Overview

Table 86. Bio-Med Polio Vaccine Product

Table 87. Bio-Med Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Bio-Med Sales Proportion of Polio Vaccine by Product in 2024

Table 89. Bio-Med Sales Proportion of Polio Vaccine by Application in 2024

Table 90. Bio-Med Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 91. Bio-Med Recent Developments

Table 92. Halfkin Bio-Pharmaceuticals Company Information

Table 93. Halfkin Bio-Pharmaceuticals Description and Business Overview

Table 94. Halfkin Bio-Pharmaceuticals Polio Vaccine Product

Table 95. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 96. Halfkin Bio-Pharmaceuticals Sales Proportion of Polio Vaccine by Product in 2024

Table 97. Halfkin Bio-Pharmaceuticals Sales Proportion of Polio Vaccine by Application in 2024

Table 98. Halfkin Bio-Pharmaceuticals Sales Proportion of Polio Vaccine by Geographic Area in 2024

Table 99. Halfkin Bio-Pharmaceuticals Recent Developments

Table 100. North America Polio Vaccine Sales by Country (2020-2025) & (K Units)

Table 101. North America Polio Vaccine Sales by Country (2026-2031) & (K Units)

Table 102. North America Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 103. North America Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 104. North America Polio Vaccine Sales by Type (2020-2025) & (K Units)

Table 105. North America Polio Vaccine Sales by Application (2020-2025) & (K Units)

Table 106. Asia-Pacific Polio Vaccine Sales by Region (2020-2025) & (K Units)

Table 107. Asia-Pacific Polio Vaccine Sales by Region (2026-2031) & (K Units)

Table 108. Asia-Pacific Polio Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 109. Asia-Pacific Polio Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 110. Asia-Pacific Polio Vaccine Sales by Type (2020-2025) & (K Units)

Table 111. Asia-Pacific Polio Vaccine Sales by Application (2020-2025) & (K Units)

Table 112. Europe Polio Vaccine Sales by Country (2020-2025) & (K Units)

Table 113. Europe Polio Vaccine Sales by Country (2026-2031) & (K Units)

Table 114. Europe Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 115. Europe Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 116. Europe Polio Vaccine Sales by Type (2020-2025) & (K Units)

Table 117. Europe Polio Vaccine Sales by Application (2020-2025) & (K Units)

Table 118. Latin America Polio Vaccine Sales by Country (2020-2025) & (K Units)

Table 119. Latin America Polio Vaccine Sales by Country (2026-2031) & (K Units)

Table 120. Latin America Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 121. Latin America Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 122. Latin America Polio Vaccine Sales by Type (2020-2025) & (K Units)

Table 123. Latin America Polio Vaccine Sales by Application (2020-2025) & (K Units)

Table 124. Middle East and Africa Polio Vaccine Sales by Country (2020-2025) & (K Units)

Table 125. Middle East and Africa Polio Vaccine Sales by Country (2026-2031) & (K Units)

Table 126. Middle East and Africa Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 127. Middle East and Africa Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 128. Middle East and Africa Polio Vaccine Sales by Type (2020-2025) & (K Units)

Table 129. Middle East and Africa Polio Vaccine Sales by Application (2020-2025) & (K Units)

Table 130. Polio Vaccine Key Raw Materials, Industry Status and Trend

Table 131. Polio Vaccine Key Raw Materials and Upstream Suppliers

Table 132. Polio Vaccine Clients Status and Trend

Table 133. Polio Vaccine Typical Clients

Table 134. Polio Vaccine Distributors

Table 135. Polio Vaccine Market Trends

Table 136. Polio Vaccine Market Drivers

Table 137. Polio Vaccine Market Challenges

Table 138. Polio Vaccine Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Polio Vaccine Product Picture

Figure 2. Global Polio Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Polio Vaccine Sales Market Share by Type in 2024 & 2031

Figure 4. Inactivated Polio Vaccine (IPV) Product Picture

Figure 5. Oral Polio Vaccine (OPV) Product Picture

Figure 6. Global Polio Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Polio Vaccine Sales Market Share by Application in 2024 & 2031

Figure 8. Public

Figure 9. Private

Figure 10. Polio Vaccine Report Years Considered

Figure 11. Global Polio Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Polio Vaccine Market Size 2020-2031 (US$ Million)

Figure 13. Global Polio Vaccine Sales 2020-2031 (K Units)

Figure 14. Global Polio Vaccine Sales Market Share Forecast by Region (2020-2031)

Figure 15. Global Polio Vaccine Revenue Market Share by Region (2020-2031)

Figure 16. Global Polio Vaccine Sales Market Share Forecast by Type (2020-2031)

Figure 17. Global Polio Vaccine Revenue Market Share Forecast by Type (2020-2031)

Figure 18. Polio Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 19. Global Polio Vaccine Sales Market Share Forecast by Application (2020-2031)

Figure 20. Global Polio Vaccine Revenue Market Share Forecast by Application (2020-2031)

Figure 21. Polio Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 22. Inactivated Polio Vaccine (IPV) of Polio Vaccine Revenue Market Share by Application, 2024 VS 2031

Figure 23. Oral Polio Vaccine (OPV) of Polio Vaccine Revenue Market Share by Application, 2024 VS 2031

Figure 24. Global Polio Vaccine Sales Share by Manufacturer in 2024

Figure 25. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. Inactivated Polio Vaccine (IPV) Market Sales Proportion by Manufacturer in 2024

Figure 27. Oral Polio Vaccine (OPV) Market Sales Proportion by Manufacturer in 2024

Figure 28. North America Polio Vaccine Revenue 2020-2031 (US$ Million)

Figure 29. North America Polio Vaccine Sales Market Share by Type (2020-2025)

Figure 30. North America Polio Vaccine Sales Market Share by Application (2020-2025)

Figure 31. Asia-Pacific Polio Vaccine Revenue 2020-2031 (US$ Million)

Figure 32. Asia-Pacific Polio Vaccine Sales Market Share by Region (2020-2031)

Figure 33. Asia-Pacific Polio Vaccine Revenue Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Polio Vaccine Sales Market Share by Type (2020-2025)

Figure 35. Asia-Pacific Polio Vaccine Sales Market Share by Application (2020-2025)

Figure 36. Europe Polio Vaccine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 37. Europe Polio Vaccine Sales Market Share by Country (2020-2031)

Figure 38. Europe Polio Vaccine Revenue Market Share by Country (2020-2031)

Figure 39. Europe Polio Vaccine Sales Market Share by Type (2020-2025)

Figure 40. Europe Polio Vaccine Sales Market Share by Application (2020-2025)

Figure 41. Latin America Polio Vaccine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Latin America Polio Vaccine Sales Market Share by Country (2020-2031)

Figure 43. Latin America Polio Vaccine Revenue Market Share by Country (2020-2025)

Figure 44. Latin America Polio Vaccine Sales Market Share by Type (2020-2025)

Figure 45. Latin America Polio Vaccine Sales Market Share by Application (2020-2025)

Figure 46. Middle East and Africa Polio Vaccine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 47. Middle East and Africa Polio Vaccine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Polio Vaccine Sales Market Share by Type (2020-2025)

Figure 50. Middle East and Africa Polio Vaccine Sales Market Share by Application (2020-2025)

Figure 51. Polio Vaccine Supply Chain (Upstream and Downstream Market)

Figure 52. Global Production Market Share of Polio Vaccine Raw Materials by Region in 2024

Figure 53. Polio Vaccine Distribution Channels

Figure 54. Global Polio Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 55. Global Polio Vaccine Percentage 2020-2031: Online Sales VS Offline Sales

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Poliomyelitis Vaccine Market Research Report 2025

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polio Vaccination Market Research Report 2025

Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Poliovirus Vaccine Inactivated Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combined Polio Vaccine Market Research Report 2024

Global Live Attenuated Polio Vaccine Market Research Report 2024

Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025

Global Vaccines For Children Market Insights Forecast to 2030

Global Oral Polio Vaccines OPV Market Research Report 2024

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rotavirus Vaccines Market Insights Forecast to 2030

Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025

Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DTaP and Tdap Vaccines Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions